Papers
27
Total Citations
589
H-Index
13
About
Dr. Yi‐Ming Shyr is a pioneering surgeon whose work has reshaped the landscape of robotic pancreatic and gastric surgery. His research focuses on advancing minimally invasive techniques for complex oncologic procedures, particularly pancreaticoduodenectomy (the Whipple procedure) and gastrectomy for gastric cancer. Dr. Shyr’s major contributions include demonstrating the safety and oncological feasibility of robotic pancreaticoduodenectomy through rigorous propensity score-matched studies, showing comparable or improved outcomes to the traditional open approach. His landmark 2018 study comparing robotic and open pancreaticoduodenectomy with modified Blumgart pancreaticojejunostomy has garnered 118 citations, while his work on vascular resection during robotic surgery (61 citations) has expanded the boundaries of what is technically possible. Dr. Shyr also led the development of the 2023 International Consensus Guidelines on Robotic Pancreatic Surgery (46 citations), establishing evidence-based standards for the field. His innovative pilot study on indocyanine green lymph node mapping in robotic gastrectomy (65 citations) has improved surgical precision in gastric cancer treatment. Through his leadership at Taipei Veterans General Hospital in Taiwan, Dr. Shyr has become a global authority in robotic hepatobiliary and pancreatic surgery, consistently advancing surgical oncology with meticulous technique and robust clinical evidence.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4International consensus guidelines on robotic pancreatic surgery in 202346 citations · 2024
- 5Mesopancreas level 3 dissection in robotic pancreaticoduodenectomy28 citations · 2020
- 6Chyle leakage after robotic and open pancreaticoduodenectomy24 citations · 2020
- 7
- 8
- 9Advances in Laparoscopic and Robotic Gastrectomy for Gastric Cancer23 citations · 2016
- 10